F Dx Advisors, Inc. Horizon Therapeutics Public LTD CO Transaction History

F Dx Advisors, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$62.39 - $113.8 $24,581 - $44,837	-394 Reduced 6.68%	5,508 $627,000
Q3 2022 Nov 10, 2022	SELL	$58.92 - $84.67 $594,915 - $854,912	-10,097 Reduced 63.11%	5,902 $365,000
Q2 2022 Aug 03, 2022	BUY	$79.4 - $116.36 $55,977 - $82,033	705 Added 4.61%	15,999 $1.28 Million
Q1 2022 May 03, 2022	SELL	$86.42 - $109.81 $72,333 - $91,910	-837 Reduced 5.19%	15,294 $1.61 Million
Q4 2021 Feb 01, 2022	BUY	$98.56 - $119.91 $61,304 - $74,584	622 Added 4.01%	16,131 $1.74 Million

Q3 2021 Oct 08, 2021	SELL	$91.91 - $110.37 $22,517 - $27,040	-245 Reduced 1.56%	15,509 $1.7 Million
Q2 2021 Aug 05, 2021	BUY	$86.24 - $95.92 $17,420 - $19,375	202 Added 1.3%	15,754 $1.48 Million
Q1 2021 Apr 14, 2021	BUY	$71.83 - $95.48 $1.01 Million - $1.35 Million	14,121 Added 986.79%	15,552 $1.43 Million
Q1 2021 Apr 13, 2021	SELL	$71.83 - $95.48 $417,906 - $555,502	-5,818 Reduced 80.26%	1,431 $131,000
Q4 2020 Feb 08, 2021	BUY	$67.0 - $84.39 $46,431 - $58,482	693 Added 10.57%	7,249 $530,000
Q3 2020 Nov 12, 2020	BUY	$55.23 - $79.93 $16,569 - $23,979	300 Added 4.8%	6,556 $509,000
Q1 2020 May 13, 2020	BUY	$24.87 - $38.56 $155,586 - $241,231	6,256 New	6,256 $837,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on F Dx Advisors, Inc. with notifications on news.